Introduction and Objective: Early CGM initiation is associated with improved HbA1c and patient satisfaction. We describe practice patterns of CGM initiation and remote-patient monitoring (RPM) across the T1D Exchange QI (T1DX-QI) consortium. Methods: The annual T1DX-QI survey was administered from August to October 2025 to collect data on frequency of communication with new onset patients, who performed the follow-up and state of RPM using CGM data. Results: Most centers (63/64, 98%) responded (67% pediatric, 33% adult centers). Follow-up was primarily managed by RN/CDCES in pediatric and by physicians in adult practices during the first month post diagnosis and by RNs in months 2-3 in both settings. Most (55%) pediatric practices started CGM within 3 days of diagnosis, compared to 29% of adult practices. Most practices (pediatrics 76% and adult 67%) connected PwT1D to the clinic CGM portals and were performing RPM. While most practices were billing for CGM interpretation at clinic visits (57% adult, 69% pediatric), few were billing for RPM between clinic visits (29% adult, 21% pediatric), despite frequent contact with PwT1D between visits. Standard protocols for RPM between visits were rare (5% adult, 17% pediatric). Conclusion: Despite widespread CGM portal connectivity and frequent between-visit contact, standardized RPM protocols and billing for between-visit care remain uncommon, highlighting opportunities to optimize care. Disclosure R. Wolf: Research Support; Current; Lilly Diabetes. Research Support; Ended; Novo Nordisk. Research Support; Current; Sanofi. Consultant; Current; Sanofi. S. Thapa: None. F.K. Bishop: None. N. Mathioudakis: None. N. Rioles: None. E.A. Brown: None. D. Maahs: Advisory Panel; Current; Abbott Diabetes, Sanofi, Medtronic, biospex, enable biosciences, kriya.
Wolf et al. (Fri,) studied this question.